Epilogue

This publication has 18 references indexed in Scilit:

• Variations among non-sedating antihistamines: are there real differences?
  European Journal of Clinical Pharmacology, 1999
• Blockade of Cardiac Potassium and Other Channels by Antihistamines
  Drug Safety, 1999
• Cardiac effects of ebastine and other antihistamines in humans.
  Drug Safety, 1999
• Molecular Basis for the Lack of HERG K+ Channel Block-Related Cardiotoxicity by the H1 Receptor Blocker Cetirizine Compared with Other Second-Generation Antihistamines
  Molecular Pharmacology, 1998
• Suppression of Mammalian K+ Channel Family by Ebastine
  The Journal of Pharmacology and Experimental Therapeutics, 1997
• Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.
  1996
• Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
  1996
• Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
  1996
• Rate-corrected QT interval: Techniques and limitations
  The American Journal of Cardiology, 1993
• Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia
  The American Journal of Cardiology, 1991